SCMP - Sucampo Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue230,056153,180115,450
Cost of Revenue76,00336,73116,269
Gross Profit154,053116,44999,181
Operating Expenses
Research Development46,61533,63120,566
Selling General and Administrative46,27638,35945,753
Non Recurring7,2867,2865,631
Total Operating Expenses---
Operating Income or Loss53,87644,45927,231
Income from Continuing Operations
Total Other Income/Expenses Net-15,7406,0701,422
Earnings Before Interest and Taxes38,13650,52928,653
Interest Expense23,7616,8541,520
Income Before Tax14,37543,67527,133
Income Tax Expense-4,11210,30414,005
Minority Interest---
Net Income From Continuing Ops18,48733,37113,128
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income18,48733,37113,128
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares18,48733,37113,128